The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Subchronic Toxicity Studies on Perfluorooctanesulfonate Potassium Salt in Cynomolgus Monkeys
Abstract
This study was conducted to determine the earliest measurable response of primates to low-level perfluorooctanesulfonate (PFOS) exposure and to provide information to reduce uncertainty in human health risk assessment. Groups of male and female monkeys received 0, 0.03, 0.15, or 0.75 mg/kg/day potassium PFOS orally for 182 days. Recovery animals from each group, except the 0.03 mg/kg/day dose group, were monitored for one year after treatment. Significant adverse effects occurred only in the 0.75 mg/kg/day dose group and included compound-related mortality in 2 of 6 male monkeys, decreased body weights, increased liver weights, lowered serum total cholesterol, lowered triiodothyronine concentrations (without evidence of hypothyroidism), and lowered estradiol levels. Decreased serum total cholesterol occurred in the 0.75 mg/kg/day dose group at serum PFOS levels > 100 ppm. Hepatocellular hypertrophy and lipid vacuolation were present at term in the 0.75 mg/kg/day dose group. No peroxisomal (palmitoyl CoA oxidase) or cell proliferation (proliferating cell nuclear antigen immunohistochemistry) was detected. Complete reversal of clinical and hepatic effects and significant decreases in serum and liver PFOS occurred within 211 days posttreatment. Liver-to-serum PFOS ratios were comparable in all dose groups, with a range of 1:1 to 2:1. Serum concentrations associated with no adverse effects (0.15 mg/kg/day) were 82.6 +/- 25.2 ppm for males and 66.8 +/- 10.8 ppm for females. Comparison of serum PFOS concentrations associated with no adverse effect in this study to those reported in human blood samples (0.028 +/- 0.014 ppm) indicated an adequate margin of safety.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“exposure to PFAS, primarily PFOS and PFOA, can lead to decreased food consumption and decreased weight gain in adult animals”
From A Critical Review and Meta-Analysis of Impacts of Per- and Polyfluorinated Substances on the Brain and Behavior (2022) · cites this paper as Seacat, 2002
Citations
Cites
Statistical principles in experimental design.
Winer, B. J. (1962) · McGraw-Hill Book Company · doi:10.1037/11774-000 · Cited by 27,137
Robust tests for equality of variances
Levene, H. (1961) · Medical Entomology and Zoology · Cited by 3,271
New Tables for Multiple Comparisons with a Control
Dunnett, C. W. (1964) · Biometrics · doi:10.2307/2528490 · Cited by 3,105
Biostatistics: A Foundation for Analysis in the Health Sciences.
Rosenfeld, B., & Daniel, W. W. (1984) · Journal of the American Statistical Association · doi:10.2307/2288760 · Cited by 2,841
Global Distribution of Perfluorooctane Sulfonate in Wildlife
Giesy, J. P., & Kannan, K. (2001) · Environmental Science & Technology · doi:10.1021/es001834k · Cited by 2,750
Ingbar, S. H. (1965) · Archives of Internal Medicine · doi:10.1001/archinte.1965.03870060154035 · Cited by 1,745
Oliver, W. R., Shenk, J. L., Snaith, M. R., RUSSELL, C. S., Plunket, K. D., Bodkin, N. L., Lewis, M. C., Winegar, D. A., Sznaidman, M. L., Lambert, M. H., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091021198 · Cited by 1,060
Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices
Hansen, K. J., Clemen, L. A., Ellefson, M. E., & Johnson, H. O. (2001) · Environmental Science & Technology · doi:10.1021/es001489z · Cited by 923
Dangerous dogmas in medicine: the nonthyroidal illness syndrome
De Groot, L. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5364 · Cited by 505
Interactions of flurochemicals with rat liver fatty acid-binding protein
Luebker, D. J., Hansen, K. J., Bass, N. M., Butenhoff, J. L., & Seacat, A. M. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00081-1 · Cited by 398
Self-citation
Flagged first, then by citations
1 of the 36 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–125 of 125
Webster, G. M., Venners, S. A., Mattman, A., & Martin, J. W. (2014) · Environmental Research · doi:10.1016/j.envres.2014.06.012 · Cited by 145
Development of PBPK models for PFOA and PFOS for human pregnancy and lactation life stages
Loccisano, A. E., Longnecker, M. P., Campbell, J. L., Andersen, M. E., & Clewell, H. J. (2013) · Journal of Toxicology and Environmental Health, Part A · doi:10.1080/15287394.2012.722523 · Cited by 141
Occurrence of perfluorinated compounds in raw water from New Jersey public drinking water systems
Post, G. B., Louis, J. B., Lippincott, R. L., & Procopio, N. A. (2013) · Environmental Science & Technology · doi:10.1021/es402884x · Cited by 130
Binding of PFOS to Serum Albumin and DNA: Insight into the Molecular Toxicity of Perfluorochemicals
Zhang, X., Chen, L., Fei, X.-C., Ma, Y.-S., & Gao, H.-W. (2009) · BMC Molecular Biology · doi:10.1186/1471-2199-10-16 · Cited by 119
Chang, S.-C., Ehresman, D. J., Bjork, J. A., Wallace, K. B., Parker, G. A., Stump, D. G., & Butenhoff, J. L. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.01.005 · Cited by 118
Bogdanska, J., Borg, D., Sundström, M., Bergström, U., Halldin, K., Abedi-Valugerdi, M., Bergman, Å., Nelson, B., DePierre, J., & Nobel, S. (2011) · Toxicology · doi:10.1016/j.tox.2011.03.014 · Cited by 109
Xia, X., Rabearisoa, A. H., Jiang, X., & Dai, Z. (2013) · Environmental Science & Technology · doi:10.1021/es401442y · Cited by 102
Chou, W.-C., & Lin, Z. (2019) · Environment International · doi:10.1016/j.envint.2019.03.058 · Cited by 98
Briels, N., Ciesielski, T. M., Herzke, D., & Jaspers, V. L. B. (2018) · Environmental Science & Technology · doi:10.1021/acs.est.8b04749 · Cited by 93
Greaves, A. K., Letcher, R. J., Sonne, C., & Dietz, R. (2013) · Environmental Toxicology and Chemistry · doi:10.1002/etc.2107 · Cited by 86
Peden-Adams, M. M., Stuckey, J. E., Gaworecki, K. M., Berger-Ritchie, J., Bryant, K., Jodice, P. G., Scott, T. R., Ferrario, J. B., Guan, B., Vigo, C., et al. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2008.10.009 · Cited by 84
Case–control study on perfluorinated alkyl acids (PFAAs) and the risk of prostate cancer
Hardell, E., Kärrman, A., van Bavel, B., Bao, J., Carlberg, M., & Hardell, L. (2014) · Environment International · doi:10.1016/j.envint.2013.10.005 · Cited by 80
Perfluoroalkyl Chemicals in Neurological Health and Disease: Human Concerns and Animal Models
Piekarski, D., Diaz, K., & McNerney, M. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.01.001 · Cited by 76
Attanasio, R. (2019) · Environmental Pollution · doi:10.1016/j.envpol.2019.113061 · Cited by 72
Wolf, C. J., Rider, C. V., Lau, C., & Abbott, B. D. (2014) · Toxicology · doi:10.1016/j.tox.2013.12.002 · Cited by 69
Kim, H.-S., Jun Kwack, S., Sik Han, E., Seok Kang, T., Hee Kim, S., & Young Han, S. (2011) · The Journal of Toxicological Sciences · doi:10.2131/jts.36.201 · Cited by 62
Airborne precursors predict maternal serum perfluoroalkyl acid concentrations
Makey, C. M., Webster, T. F., Martin, J. W., Shoeib, M., Harner, T., Dix-Cooper, L., & Webster, G. M. (2017) · Environmental Science & Technology · doi:10.1021/acs.est.7b00615 · Cited by 54
Why Toxic Equivalency Factors Are Not Suitable for Perfluoroalkyl Chemicals
Peters, J. M., & Gonzalez, F. J. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200316x · Cited by 48
Half-lives of several polyfluoroalkyl substances (PFAS) in cattle serum and tissues
Drew, R., Hagen, T. G., Champness, D., & Sellier, A. (2022) · Food Additives & Contaminants: Part A · doi:10.1080/19440049.2021.1991004 · Cited by 42
Pirali, B., Negri, S., Chytiris, S., Perissi, A., Villani, L., La Manna, L., Cottica, D., Ferrari, M., Imbriani, M., Rotondi, M., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0174 · Cited by 38
Fang, X., Wu, C., Li, H., Yuan, W., & Wang, X. (2018) · Toxicology and Industrial Health · doi:10.1177/0748233717742262 · Cited by 36
Perfluorooctane Sulfonate Influences Feeding Behavior and Gut Motility via the Hypothalamus
Asakawa, A., Toyoshima, M., Fujimiya, M., Harada, K., Ataka, K., Inoue, K., & Koizumi, A. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.19.5.733 · Cited by 33
Perfluorooctane Sulfonate Induces Neuronal Vulnerability by Decreasing GluR2 Expression
Ishida, K., Tsuyama, Y., Sanoh, S., Ohta, S., & Kotake, Y. (2017) · Archives of Toxicology · doi:10.1007/s00204-016-1731-x · Cited by 27
Yang, M., Su, W., Li, H., Li, L., An, Z., Xiao, F., Liu, Y., Zhang, X., Liu, X., Guo, H., et al. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115473 · Cited by 23
East, A., Dawson, D. E., Brady, S., Vallero, D. A., & Tornero-Velez, R. (2023) · Toxics · doi:10.3390/toxics11020163 · Cited by 14
Metadata
- Authors
- Seacat, A. M.
- Affiliations
- 3M (United States) (US)
- Corresponding author
- Seacat, A. M.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-07-01
- Volume
- 68
- Issue
- 1
- Pages
- 249-264
- ISSN
- 1096-0929 (ISSN-L)
- OpenAlex
- W2127286660
- Cited by
- 564
- References
- 36
- Citations by year
- 2026: 6 · 2025: 25 · 2024: 16 · 2023: 18 · 2022: 12 · 2021: 25 · 2020: 27 · 2019: 23 · 2018: 31 · 2017: 17 · 2016: 25 · 2015: 31 · 2014: 24 · 2013: 24 · 2012: 35
- FWCI
- 12.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Toxicological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Environmental Science › Environmental Chemistry › Per- and polyfluoroalkyl substances research
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
- Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
- Keywords
- PFOS, subchronic toxicity, Macaca fascicularis, hepatocyte hypertrophy, total cholesterol, triiodothyronine, estradiol, recovery after treatment, safety margin, human health risk assessment, peroxisomal function, cell proliferation
- MeSH terms
- Administration, Oral, Animals, Body Weight, Cell Division, Dose-Response Relationship, Drug, Female, Fluorocarbons, Immunohistochemistry, Liver, Longevity, Macaca fascicularis, Male, Organ Size, Remission Induction, Alkanesulfonic Acids, Toxicity Tests, Proliferating Cell Nuclear Antigen, Peroxisomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
